menu
    • menu

    Company profile for Extrovis AG

    NEW Drugs in Dev: 1
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Extrovis is a global pharmaceutical company based in Switzerland with subsidiaries in Hungary and India. The Indian unit employs 60 scientists and researchers focused on developing complex APIs and finished dosage forms for pharmaceutical products. The company has established a presence in Hungary to support its plans for entering the European market and employs a team for supply chain, regulatory, pharmacovigilance and custom...
    Extrovis is a global pharmaceutical company based in Switzerland with subsidiaries in Hungary and India. The Indian unit employs 60 scientists and researchers focused on developing complex APIs and finished dosage forms for pharmaceutical products. The company has established a presence in Hungary to support its plans for entering the European market and employs a team for supply chain, regulatory, pharmacovigilance and customer service. Extrovis' portfolio includes niche generic products, products with formulation improvements, and redesigned products for patient safety and convenience, mostly as drug-device combinations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Extrovis AGSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Bahnhof-Park 4, Baar 6340
    Telephone
    Telephone
    +41 799697055
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.extrovis.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/extrovis-pvt-ltd
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Extrovis’ Generics Na Acetate Receives Approval in US
    Extrovis’ Generics Na Acetate Receives Approval in US

    17 Apr 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220274

    FDA
    17 Apr 2026
    Share Share
    Extrovis & Dr Reddy’s launch Generic Fluorouracil Cream
    Extrovis & Dr Reddy’s launch Generic Fluorouracil Cream

    21 Aug 2025

    // PRESS RELEASE

    https://www.expresspharma.in/extrovis-ag-and-dr-reddys-launch-authorised-generic-fluorouracil-cream-0-5-per-cent-in-us-market/

    PRESS RELEASE
    21 Aug 2025
    Share Share
    Extrovis' Sugammadex Receives Approval in Europe
    Extrovis' Sugammadex Receives Approval in Europe

    16 Jun 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/sugammadex-adroiq-epar-medicine-overview_en.pdf

    EMA
    16 Jun 2023
    Share Share
    Extrovis' Lacosamide Adroiq (lacosamide) Receives Approval in Europe
    Extrovis' Lacosamide Adroiq (lacosamide) Receives Approval in Europe

    05 Jun 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/lacosamide-adroiq-epar-medicine-overview_en.pdf

    EMA
    05 Jun 2023
    Share Share
    Megasoft completed the acquisition of 40% stake in Extrovis AG.
    Megasoft completed the acquisition of 40% stake in Extrovis AG.

    19 Jan 2023

    // MARKET SCREENER

    https://www.marketscreener.com/quote/stock/MEGASOFT-LIMITED-6498580/news/Megasoft-Limited-completed-the-acquisition-of-40-stake-in-Extrovis-AG-42781952/

    MARKET SCREENER
    19 Jan 2023
    Share Share
    Megasoft Limited agreed to acquire 40% stake in EXTROVIS AG for $16 million.
    Megasoft Limited agreed to acquire 40% stake in EXTROVIS AG for $16 million.

    15 May 2022

    // MARKETSCREENER

    https://www.marketscreener.com/quote/stock/MEGASOFT-LIMITED-6498580/news/Megasoft-Limited-agreed-to-acquire-40-stake-in-EXTROVIS-AG-for-16-million-40454341/

    MARKETSCREENER
    15 May 2022
    Share Share

    FDF Dossiers

    read-more
    read-more

    01

    Brand Name : AZITHROMYCIN

    Switzerland
    Arvo
    Not Confirmed
    arrow

    Brand Name : AZITHROMYCIN

    Switzerland
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    AZITHROMYCIN

    Extrovis AG

    Dosage Form : TABLET;ORAL

    Brand Name : AZITHROMYCIN

    Dosage Strength : EQ 500MG BASE

    Packaging :

    Approval Date : 2007-05-30

    Application Number : 65366

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : CALCIUM CHLORIDE 10%

    Switzerland
    Arvo
    Not Confirmed
    arrow

    Brand Name : CALCIUM CHLORIDE 10%

    Switzerland
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    CALCIUM CHLORIDE

    Extrovis AG

    Dosage Form : INJECTABLE;INJECTION

    Brand Name : CALCIUM CHLORIDE 10%

    Dosage Strength : 100MG/ML

    Packaging :

    Approval Date : 2024-11-27

    Application Number : 219342

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : CLINDAMYCIN PALMITAT...

    Switzerland
    Arvo
    Not Confirmed
    arrow

    Brand Name : CLINDAMYCIN PALMITAT...

    Switzerland
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    CLINDAMYCIN PALMITATE HYDROCHLORIDE

    Extrovis AG

    Dosage Form : FOR SOLUTION;ORAL

    Brand Name : CLINDAMYCIN PALMITATE HYD...

    Dosage Strength : EQ 75MG BASE/5ML

    Packaging :

    Approval Date : 2016-05-25

    Application Number : 203063

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : FLUDARABINE PHOSPHAT...

    Switzerland
    Arvo
    Not Confirmed
    arrow

    Brand Name : FLUDARABINE PHOSPHAT...

    Switzerland
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    FLUDARABINE PHOSPHATE

    Extrovis AG

    Dosage Form : INJECTABLE;INJECTION

    Brand Name : FLUDARABINE PHOSPHATE

    Dosage Strength : 50MG/2ML (25MG/ML)

    Packaging :

    Approval Date : 2011-12-21

    Application Number : 200647

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : EFUDEX

    Switzerland
    Arvo
    Not Confirmed
    arrow

    Brand Name : EFUDEX

    Switzerland
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    FLUOROURACIL

    Extrovis AG

    Dosage Form : SOLUTION;TOPICAL

    Brand Name : EFUDEX

    Dosage Strength : 2%

    Packaging :

    Approval Date : 1982-01-01

    Application Number : 16831

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : EFUDEX

    Switzerland
    Arvo
    Not Confirmed
    arrow

    Brand Name : EFUDEX

    Switzerland
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    FLUOROURACIL

    Extrovis AG

    Dosage Form : SOLUTION;TOPICAL

    Brand Name : EFUDEX

    Dosage Strength : 5% **Federal Register ...

    Packaging :

    Approval Date : 1982-01-01

    Application Number : 16831

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : EFUDEX

    Switzerland
    Arvo
    Not Confirmed
    arrow

    Brand Name : EFUDEX

    Switzerland
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    FLUOROURACIL

    Extrovis AG

    Dosage Form : CREAM;TOPICAL

    Brand Name : EFUDEX

    Dosage Strength : 5%

    Packaging :

    Approval Date : 1982-01-01

    Application Number : 16831

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : CARAC

    Switzerland
    Arvo
    Not Confirmed
    arrow

    Brand Name : CARAC

    Switzerland
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : RX

    Registration Country : USA

    FLUOROURACIL

    Extrovis AG

    Dosage Form : CREAM;TOPICAL

    Brand Name : CARAC

    Dosage Strength : 0.5%

    Packaging :

    Approval Date : 2000-10-27

    Application Number : 20985

    Regulatory Info : RX

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : FLUOROURACIL

    Switzerland
    Arvo
    Not Confirmed
    arrow

    Brand Name : FLUOROURACIL

    Switzerland
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    FLUOROURACIL

    Extrovis AG

    Dosage Form : CREAM;TOPICAL

    Brand Name : FLUOROURACIL

    Dosage Strength : 0.5%

    Packaging :

    Approval Date : 2015-04-20

    Application Number : 203122

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : IFOSFAMIDE

    Switzerland
    Arvo
    Not Confirmed
    arrow

    Brand Name : IFOSFAMIDE

    Switzerland
    arrow
    Arvo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    IFOSFAMIDE

    Extrovis AG

    Dosage Form : INJECTABLE;INJECTION

    Brand Name : IFOSFAMIDE

    Dosage Strength : 1GM/20ML (50MG/ML)

    Packaging :

    Approval Date : 2012-11-26

    Application Number : 201689

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDA Orange Book

    read-more
    read-more

    Services

    Upload your portfolio for free, ask us

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Contact Extrovis AG and get a quotation

    Extrovis AG is a supplier offers 9 products (APIs, Excipients or Intermediates).

    Find Dapsone bulk with DMF, CEP offered by Extrovis AG

    Find Avibactam Sodium bulk with DMF offered by Extrovis AG

    Find Calcium Gluconate bulk with DMF offered by Extrovis AG

    Find Eltrombopag bulk with DMF offered by Extrovis AG

    Find Potassium Dihydrogen Phosphate bulk with DMF offered by Extrovis AG

    Find Potassium Phosphate bulk with DMF offered by Extrovis AG

    Find Tolvaptan bulk with DMF offered by Extrovis AG

    Find Trabectedin bulk with DMF offered by Extrovis AG

    Find Sugammadex Sodium bulk offered by Extrovis AG

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search